MedPath

Glenmark Pharmaceuticals s.r.o.

🇨🇿Czech Republic
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

38

CIMA_AEMPS:36
EMA:2

Drug Approvals

Olazax

Authorization Status
Authorised
Approval Date
Dec 11, 2009
EMA

Olazax Disperzi

Authorization Status
Authorised
Approval Date
Dec 10, 2009
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.